A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Single Ascending Doses of ABBV-1451 Infusions and Injections in Healthy Adult Participants
Abroad (travel likely)RecruitingPHASE1
Conditions
Healthy Volunteer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Acpru /Id# 282128, Grayslake, Illinois, United States
Study leads
ABBVIE INC.
Study Director
AbbVie